{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T19:06:02Z","timestamp":1794942362216,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["CDF972"],"award-info":[{"award-number":["CDF972"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Monitoring of adherence to antiretroviral treatment (ART) is of utmost importance to prevent treatment failure. Several measures to monitor adherence have been applied in low-resource settings and they all have pros and cons. Our objective was to examine whether any of the following adherence measures is a better predictor of participants\u2019 viral load suppression: (1) self-report, (2) pharmacy refill count, (3) Real Time Medication Monitoring (RTMM), (4) a combination of self-report and pharmacy refill count or (5) all three adherence assessment methods combined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methodology<\/jats:title>\n                <jats:p>This was a post-hoc analysis of data from our 48-week REMIND-HIV randomized controlled trial in which adherence to ART was measured using self-report, pharmacy refill counts and RTMM among ART-experienced adults living with HIV subjectively judged to be nonadherent to ART. For each adherence measure, we calculated sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for predicting virological failure defined as a viral load (VL) of\u2009&gt;\u200920 copies\/mL. To determine at which percentage of adherence the prediction was strongest, we evaluated adherence cut-offs of 80%, 85%, 90%, 95% and 100% using receiver operating characteristic (ROC) curves. VL data were obtained after 48\u00a0weeks of follow-up in the trial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 233 people living with HIV (PLHIV) were included in this analysis. When comparing the ability of self-reported adherence with pharmacy refill count and RTMM adherence to predict viral load\u2009&gt;\u200920 copies\/ml, self-reported adherence had the lowest sensitivity, ranging from 6 to 17%, but the highest specificity, ranging from 100 to 86%, depending on cut-off values from 80 to 100%. Area under the ROC curves (AUC) were 0.54 for RTMM, 0.56 for pharmacy refill count and 0.52 for self-report, indicating low discriminatory capacity for each of the adherence measures. When we combined the self-report and pharmacy refill count measures, sensitivity increased, ranging from 28 to 57% but specificity decreased, ranging from 83 to 53%. When all three measures were combined, we observed the highest value of sensitivity, ranging from 46 to 92%, and PPV, ranging from 32 to 36%, at high cut-offs ranging from 80 to 100%. Upon combination of three adherence measures, the AUC increased to 0.59.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our results show that adherence assessed exclusively by self-report, pharmacy refill count or RTMM were insufficiently sensitive to predict virologic failure. Sensitivity markedly improved by combining all three measures, but the practical feasibility of such an approach would need to be studied.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12981-022-00475-y","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T09:02:43Z","timestamp":1668502963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Predicting viral load suppression by self-reported adherence, pharmacy refill counts and real time medication monitoring among people living with HIV in Tanzania"],"prefix":"10.1186","volume":"19","author":[{"given":"Kennedy M.","family":"Ngowi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Minja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Marion Sumari-de","family":"Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob E.","family":"Aarnoutse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyidia","family":"Masika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam A. G.","family":"Sprangers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis M.","family":"Pima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blandina T.","family":"Mmbaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pythia T.","family":"Nieuwkerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"issue":"5209","key":"475_CR1","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1126\/science.7716530","volume":"268","author":"LUS Ianniello","year":"1995","unstructured":"Ianniello LUS. Neutron sources. Science. 1995;268(5209):350\u2013350.","journal-title":"Science"},{"issue":"5","key":"475_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11606-002-0044-3","volume":"17","author":"JH Arnsten","year":"2002","unstructured":"Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegan H, Howard AA, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002;17(5):377\u201381.","journal-title":"J Gen Intern Med"},{"key":"475_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013080","author":"P Hine","year":"2018","unstructured":"Hine P, Smith R, Eshun-Wilson I, Orrell C, Cohen K, Leeflang MMG, et al. Measures of antiretroviral adherence for detecting viral non-suppression in people living with HIV. Cochrane Database Syst Rev. 2018. https:\/\/doi.org\/10.1002\/14651858.CD013080.","journal-title":"Cochrane Database Syst Rev"},{"key":"475_CR4","unstructured":"UNAIDS. Data 2020. Program HIV\/AIDS [Internet]. 2020;1\u2013436. Available from: http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/20170720_Data_book_2017_en.pdf."},{"issue":"1","key":"475_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7448\/IAS.20.1.21218","volume":"20","author":"R Bijker","year":"2017","unstructured":"Bijker R, Jiamsakul A, Kityo C, Kiertiburanakul S, Siwale M, Phanuphak P, et al. Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts. J Int AIDS Soc. 2017;20(1):1\u201310.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"475_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","volume":"133","author":"DL Paterson","year":"2000","unstructured":"Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21\u201330.","journal-title":"Ann Intern Med"},{"issue":"1","key":"475_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-017-2892-9","volume":"18","author":"OV Adeniyi","year":"2018","unstructured":"Adeniyi OV, Ajayi AI, Ter Goon D, Owolabi EO, Eboh A, Lambert J. Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape. South Africa BMC Infect Dis. 2018;18(1):1\u201311.","journal-title":"South Africa BMC Infect Dis"},{"issue":"2","key":"475_CR8","first-page":"68","volume":"55","author":"V Kaleva","year":"2015","unstructured":"Kaleva V. Adherence to medication. Pediatriya. 2015;55(2):68\u20139.","journal-title":"Pediatriya"},{"issue":"2","key":"475_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1177\/2325957414557263","volume":"14","author":"L Kabore","year":"2015","unstructured":"Kabore L, Muntner P, Chamot E, Zinski A, Burkholder G, Mugavero MJ. Self-report measures in the assessment of antiretroviral medication adherence: comparison with medication possession ratio and HIV viral load. J Int Assoc Provid AIDS Care. 2015;14(2):156\u201362.","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"8","key":"475_CR10","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1007\/s10461-019-02448-1","volume":"23","author":"L Craker","year":"2019","unstructured":"Craker L, Tarantino N, Whiteley L, Brown L. Measuring antiretroviral adherence among young people living with HIV: observations from a real-time monitoring device versus self-report. AIDS Behav. 2019;23(8):2138\u201345. https:\/\/doi.org\/10.1007\/s10461-019-02448-1.","journal-title":"AIDS Behav"},{"issue":"12","key":"475_CR11","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2165\/11537400-000000000-00000","volume":"28","author":"L Shi","year":"2010","unstructured":"Shi L, Liu J, Koleva Y, Fonseca V, Kalsekar A, Pawaskar M. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. Pharmacoeconomics. 2010;28(12):1097\u2013107. https:\/\/doi.org\/10.2165\/11537400-000000000-00000.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"475_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-016-3278-4","volume":"16","author":"C Evans","year":"2016","unstructured":"Evans C, Turner K, Suggs LS, Occa A, Juma A, Blake H. Developing a mHealth intervention to promote uptake of HIV testing among African communities in the conditions: A qualitative study. BMC Public Health. 2016;16(1):1\u201316. https:\/\/doi.org\/10.1186\/s12889-016-3278-4.","journal-title":"BMC Public Health."},{"issue":"7","key":"475_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0000000000006078","volume":"96","author":"AR Patel","year":"2017","unstructured":"Patel AR, Kessler J, Braithwaite RS, Nucifora KA, Thirumurthy H, Zhou Q, et al. Economic evaluation of mobile phone text message interventions to improve adherence to HIV therapy in Kenya. Medicine. 2017;96(7):1\u20139.","journal-title":"Medicine"},{"issue":"1","key":"475_CR14","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1186\/s12889-019-6899-6","volume":"19","author":"R Shah","year":"2019","unstructured":"Shah R, Watson J, Free C. A systematic review and meta-analysis in the effectiveness of mobile phone interventions used to improve adherence to antiretroviral therapy in HIV infection. BMC Public Health. 2019;19(1):915.","journal-title":"BMC Public Health"},{"issue":"6","key":"475_CR15","doi-asserted-by":"publisher","first-page":"e14649","DOI":"10.2196\/14649","volume":"4","author":"KM Ngowi","year":"2020","unstructured":"Ngowi KM, Lyamuya F, Mmbaga BT, Muro E, Hillu Z, Shirima M, et al. Technical and psychosocial challenges of mhealth usage for antiretroviral therapy adherence among people living with HIV in a resource-limited setting: case series. JMIR Form Res. 2020;4(6):e14649.","journal-title":"JMIR Form Res"},{"key":"475_CR16","first-page":"1098109","volume":"2020","author":"S Kamal","year":"2020","unstructured":"Kamal S, Rosen MI, Lazar C, Siqueiros L, Wang Y, Daar ES, et al. Perceptions of people living with HIV and HIV healthcare providers on real-time measuring and monitoring of antiretroviral adherence using ingestible sensors: a qualitative study. AIDS Res Treat. 2020;2020:1098109.","journal-title":"AIDS Res Treat"},{"issue":"4","key":"475_CR17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.cct.2012.03.008","volume":"33","author":"LA DiCarlo","year":"2012","unstructured":"DiCarlo LA. Role for direct electronic verification of pharmaceutical ingestion in pharmaceutical development. Contemp Clin Trials. 2012;33(4):593\u2013600. https:\/\/doi.org\/10.1016\/j.cct.2012.03.008.","journal-title":"Contemp Clin Trials"},{"issue":"3","key":"475_CR18","first-page":"329","volume":"25","author":"AJ Levine","year":"2006","unstructured":"Levine AJ, Hinkin CH, Marion S, Keuning A, Castellon SA, Lam MM, et al. Adherence to antiretroviral medications in HIV: differences in data collected via self-report and electronic monitoring. Heal Psychol Off J Div Heal Psychol Am Psychol Assoc. 2006;25(3):329\u201335.","journal-title":"Heal Psychol Off J Div Heal Psychol Am Psychol Assoc"},{"issue":"7","key":"475_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0021795","volume":"6","author":"PC Mutevedzi","year":"2011","unstructured":"Mutevedzi PC, Lessells RJ, Rodger AJ, Newell ML. Association of age with mortality and virological and immunological response to antiretroviral therapy in rural south african adults. PLoS ONE. 2011;6(7):1\u20138.","journal-title":"PLoS ONE"},{"issue":"5","key":"475_CR20","first-page":"1","volume":"20","author":"A Musiimenta","year":"2018","unstructured":"Musiimenta A, Atukunda EC, Tumuhimbise W, Pisarski EE, Tam M, Wyatt MA, et al. Acceptability and feasibility of real-time antiretroviral therapy adherence interventions in rural Uganda: Mixed-method pilot randomized controlled trial. J Med Internet Res. 2018;20(5):1\u201321.","journal-title":"J Med Internet Res"},{"key":"475_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10461-006-9133-3","volume":"2","author":"CR Pearson","year":"2007","unstructured":"Pearson CR, Simoni JM, Hoff P, Kurth AE, Martin DP. Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues. AIDS Behav. 2007;2:161\u201373.","journal-title":"AIDS Behav"},{"issue":"11","key":"475_CR22","doi-asserted-by":"publisher","first-page":"e0186912","DOI":"10.1371\/journal.pone.0186912","volume":"12","author":"SK Been","year":"2017","unstructured":"Been SK, Yildiz E, Nieuwkerk PT, Pog\u00e1ny K, van de Vijver DAMC, Verbon A. Self-reported adherence and pharmacy refill adherence are both predictive for an undetectable viral load among HIV-infected migrants receiving cART. PLoS ONE. 2017;12(11):e0186912.","journal-title":"PLoS ONE"},{"issue":"1","key":"475_CR23","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1186\/1471-2458-14-1035","volume":"14","author":"RZ Sangeda","year":"2014","unstructured":"Sangeda RZ, Mosha F, Prosperi M, Aboud S, Vercauteren J, Camacho RJ, et al. Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings. BMC Public Health. 2014;14(1):1035. https:\/\/doi.org\/10.1186\/1471-2458-14-1035.","journal-title":"BMC Public Health"},{"issue":"3","key":"475_CR24","doi-asserted-by":"publisher","first-page":"e0214014","DOI":"10.1371\/journal.pone.0214014","volume":"14","author":"G Martelli","year":"2019","unstructured":"Martelli G, Antonucci R, Mukurasi A, Zepherine H, N\u00f6stlinger C. Adherence to antiretroviral treatment among children and adolescents in Tanzania: comparison between pill count and viral load outcomes in a rural context of Mwanza region. PLoS ONE. 2019;14(3):e0214014.","journal-title":"PLoS ONE"},{"key":"475_CR25","doi-asserted-by":"crossref","unstructured":"Sumari-de Boer IM, Ngowi KM, Sonda TB, Pima FM, Masika L V., Sprangers MAG, et al. Effect of Digital Adherence Tools on Adherence to Antiretroviral Treatment Among Adults Living With HIV in Kilimanjaro, Tanzania: A Randomized Controlled Trial. J Acquir Immune Defic Syndr. 2021;87(5):1136\u201344.","DOI":"10.1097\/QAI.0000000000002695"},{"issue":"2","key":"475_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"key":"475_CR27","unstructured":"NBS. The United Republic of Tanzania. Development. 2019;7(5,371,780,231.09):2,274,923,575.00\u201329.08."},{"issue":"5","key":"475_CR28","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/QAI.0b013e3181fba6ab","volume":"55","author":"IM De Boer","year":"2010","unstructured":"De Boer IM, Prins JM, Sprangers MAG, Nieuwkerk PT. Using different calculations of pharmacy refill adherence to predict virological failure among HIV-infected patients. J Acquir Immune Defic Syndr. 2010;55(5):635\u201340.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"475_CR29","first-page":"266","volume":"2020","author":"Ministry of health","year":"2019","unstructured":"Ministry of health. community development, gender, elderly a, children t National guidelines for the management of HIV and AIDS. World Popul Policies. 2019;2020:266\u20137.","journal-title":"World Popul Policies"},{"issue":"4","key":"475_CR30","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.2307\/2532419","volume":"47","author":"AJ Scott","year":"1991","unstructured":"Scott AJ, Hosmer DW, Lemeshow S. Applied logistic regression. Biometrics. 1991;47(4):1632.","journal-title":"Biometrics"},{"issue":"11","key":"475_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0186912","volume":"12","author":"SK Been","year":"2017","unstructured":"Been SK, Yildiz E, Nieuwkerk PT, Pog\u00e1ny K, Van De Vijver DAMC, Verbon A. Self-reported adherence and pharmacy refill adherence are both predictive for an undetectable viral load among HIV-infected migrants receiving cART. PLoS ONE. 2017;12(11):1\u201312.","journal-title":"PLoS ONE"},{"issue":"1","key":"475_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-14-1035","volume":"14","author":"RZ Sangeda","year":"2014","unstructured":"Sangeda RZ, Mosha F, Prosperi M, Aboud S, Vercauteren J, Camacho RJ, et al. Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings. BMC Public Health. 2014;14(1):1\u201311.","journal-title":"BMC Public Health"},{"key":"475_CR33","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2147\/PPA.S200058","volume":"13","author":"L Al-Hassany","year":"2019","unstructured":"Al-Hassany L, Kloosterboer SM, Dierckx B, Koch BCP. Assessing methods of measuring medication adherence in chronically ill children\u2013a narrative review. Patient Prefer Adherence. 2019;13:1175\u201389.","journal-title":"Patient Prefer Adherence"},{"key":"475_CR34","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s13142-015-0315-2","volume":"4","author":"MJ Stirratt","year":"2015","unstructured":"Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;4:470\u201382.","journal-title":"Transl Behav Med"},{"issue":"7","key":"475_CR35","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/tmi.12709","volume":"21","author":"LA Mekuria","year":"2016","unstructured":"Mekuria LA, Prins JM, Yalew AW, Sprangers MAG, Nieuwkerk PT. Which adherence measure\u2014self-report, clinician recorded or pharmacy refill\u2014is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring? Trop Med Int Heal. 2016;21(7):856\u201369.","journal-title":"Trop Med Int Heal"},{"issue":"5","key":"475_CR36","first-page":"139","volume":"176","author":"L Genn","year":"2018","unstructured":"Genn L, Chapman J, Okatch H, Abell N, Marukutira T, Tshume O, Anabwani G, LE Gross R. Pharmacy refill data are poor predictors of virologic treatment outcomes in adolescents with HIV in Botswana. Physiol Behav. 2018;176(5):139\u201348.","journal-title":"Physiol Behav"},{"issue":"8","key":"475_CR37","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1007\/s10461-018-2325-9","volume":"23","author":"L Genn","year":"2019","unstructured":"Genn L, Chapman J, Okatch H, Abell N, Marukutira T, Tshume O, et al. Pharmacy refill data are poor predictors of virologic treatment outcomes in adolescents with HIV in botswana. AIDS Behav. 2019;23(8):2130\u20137.","journal-title":"AIDS Behav"},{"issue":"1","key":"475_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-017-0138-y","volume":"14","author":"C Orrell","year":"2017","unstructured":"Orrell C, Cohen K, Leisegang R, Bangsberg DR, Wood R, Maartens G. Comparison of six methods to estimate adherence in an ART-na\u00efve cohort in a resource-poor setting: Which best predicts virological and resistance outcomes? AIDS Res Ther. 2017;14(1):1\u201311.","journal-title":"AIDS Res Ther"},{"issue":"12","key":"475_CR39","doi-asserted-by":"publisher","first-page":"e0167654","DOI":"10.1371\/journal.pone.0167654","volume":"11","author":"AN Phillips","year":"2016","unstructured":"Phillips AN, Cambiano V, Nakagawa F, Bansi-Matharu L, Sow PS, Ehrenkranz P, et al. Cost effectiveness of potential ART adherence monitoring interventions in Sub-Saharan Africa. PLoS ONE. 2016;11(12):e0167654.","journal-title":"PLoS ONE"},{"issue":"1","key":"475_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12981-021-00365-9","volume":"18","author":"M Abdu","year":"2021","unstructured":"Abdu M, Walelgn B. Determinant factors for adherence to antiretroviral therapy among adult HIV patients at dessie referral hospital, South Wollo, Northeast Ethiopia: a case\u2013control study. AIDS Res Ther. 2021;18(1):39. https:\/\/doi.org\/10.1186\/s12981-021-00365-9.","journal-title":"AIDS Res Ther"},{"key":"475_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/DHPS.S143178","volume":"10","author":"RZ Sangeda","year":"2018","unstructured":"Sangeda RZ, Mosha F, Aboud S, Kamuhabwa A, Chalamilla G, Vercauteren J, et al. Predictors of non adherence to antiretroviral therapy at an urban HIV care and treatment center in Tanzania. Drug Healthc Patient Saf. 2018;10:79\u201388.","journal-title":"Drug Healthc Patient Saf"},{"issue":"1","key":"475_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12981-020-00313-z","volume":"17","author":"KM Ngowi","year":"2020","unstructured":"Ngowi KM, Masika L, Lyamuya F, Muro E, Mmbaga BT, Sprangers MAG, et al. Returning of antiretroviral medication dispensed over a period of 8\u00a0months suggests non-adherence despite full adherence according to real time medication monitoring. AIDS Res Ther. 2020;17(1):57. https:\/\/doi.org\/10.1186\/s12981-020-00313-z.","journal-title":"AIDS Res Ther"},{"issue":"1","key":"475_CR43","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12981-020-00265-4","volume":"17","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Li X, Qiao S, Shen Z, Zhou Y. Comparing self-reported medication adherence measures with hair antiretroviral concentration among people living with HIV in Guangxi, China. AIDS Res Ther. 2020;17(1):8. https:\/\/doi.org\/10.1186\/s12981-020-00265-4.","journal-title":"AIDS Res Ther."},{"key":"475_CR44","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6113.1000731","author":"S Erb","year":"2017","unstructured":"Erb S, Letang E, Glass T, Natamatungiro A, Mnzava D, Mapesi H, et al. A simple visual analog scale is a valuable tool to assess self-reported adherence in hiv-infected patients on antiretroviral treatment in a resource-limited setting. J AIDS Clin Res. 2017. https:\/\/doi.org\/10.4172\/2155-6113.1000731.","journal-title":"J AIDS Clin Res"},{"key":"475_CR45","first-page":"1","volume":"4","author":"KM Ngowi","year":"2019","unstructured":"Ngowi KM, Lyamuya F, Mmbaga B, Muro E, Hillu Z, Aarnoutse RE, et al. Technical and psychosocial challenges of mobile health usage for antiretroviral therapy (ART) adherence among people living with HIV in a resource limited setting: case series (Preprint). JMIR Form Res. 2019;4:1\u20139.","journal-title":"JMIR Form Res"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-022-00475-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-022-00475-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-022-00475-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T09:03:33Z","timestamp":1668503013000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-022-00475-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1186\/s12981-022-00475-y","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"assertion":[{"value":"15 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Kilimanjaro Christian Medical College Research Ethics and Review Committee (CRERC) and the National Health Research Ethics Sub-Committee (NathRec) of Tanzania. Written informed consent was requested from study participants before enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests. All authors have read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}